Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2026-01-04 @ 6:36 PM
Study NCT ID:
NCT05274269
Status:
COMPLETED
Last Update Posted:
2024-08-01
First Post:
2022-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis Subjects Without an F508del Mutation
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VX21-445-124
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None